Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing SBRT versus TACE as a bridge to liver transplantation for hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Stereotactic Body Radiation Therapy (SBRT)
• Trans-Arterial Chemoembolization

Snippet

Sponsor: Lahey Clinic | Conditions: Hepatocellular Carcinoma, HCC | Phase 2 | Status: COMPLETED | Results posted: 2024-03-05